Physician profile
Douglas E Campbell
NPI 1366442360
$2,396.27
in general payments reported to CMS, 2019-2025
7 companies · $197 in 2025
The $197 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.04 · 2020: $246 · 2021: $349 · 2022: $437 · 2023: $796 · 2024: $274 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795 · Travel and Lodging: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.68 |
| Travel and Lodging | $472.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $738.25 | 2020-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $705.38 | 2023-2024 | |
| Abbvie INC. | $538.36 | 2021-2025 | Dalvance, Avycaz |
| Advanced Oxygen Therapy INC. | $173.41 | 2020-2022 | |
| Smith+Nephew, INC. | $166.49 | 2019-2025 | Collagenase Santyl, Regranex |
| Nevro Corp. | $50.40 | 2022 | |
| Kerecis Limited | $23.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.